Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2020-06-25 Regulatory Filings
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2020-06-25 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that top line data from the FABOLUS-FASTER clinical trial will be presented at a medical conference (PCR e-Course) on June 27, 2020. It provides details about the trial, the presentation, and safety information about the drug AGGRASTAT. There are no financial statements, regulatory filings, or detailed financial data. The document is an announcement of clinical trial results presentation rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is a corporate announcement related to clinical trial data presentation, which is best classified as a Regulatory Filing (RNS) since it does not fit other specific categories and is a general corporate announcement.
2020-06-15 English
Management information circular - English.pdf
Regulatory Filings
2020-06-05 English
Notice of meeting - English.pdf
AGM Information Classification · 95% confidence The document is a Notice of Annual Meeting of Shareholders for Medicure Inc., detailing the date, location, agenda items including receiving audited financial statements, electing directors, appointing auditors, and other business. It includes instructions for shareholders on voting and proxy submission. The document is short (2914 characters) and serves as an announcement for the upcoming Annual General Meeting (AGM), not the AGM materials or minutes themselves. Therefore, it fits the category of AGM Information (AGM-R) as it is a notice related to the AGM.
2020-06-05 English
Form of proxy - English.pdf
Regulatory Filings
2020-06-05 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2020. The document is a certification letter, not the interim report itself, and it explicitly states it is a certificate under National Instrument 52-109. The document length is short (3011 characters) and contains no actual financial data or analysis, only attestation. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR).
2020-05-12 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.